Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,388 | -4,989 | -13,209 | -13,901 | -9,668 |
| Depreciation Amortization | 521 | 645 | 712 | 134 | 131 |
| Accounts receivable | -24 | -69 | 118 | -194 | N/A |
| Accounts payable and accrued liabilities | -33 | -107 | -57 | -720 | 941 |
| Other Working Capital | 510 | -563 | 366 | -1,372 | 758 |
| Other Operating Activity | 851 | 1,395 | 1,026 | 2,375 | 800 |
| Operating Cash Flow | $-5,563 | $-3,688 | $-11,044 | $-13,678 | $-7,038 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 10,873 | 308 | 2,133 | 6,276 | -19,986 |
| PPE Investments | -75 | -200 | -135 | -23 | -147 |
| Purchase Sale Intangibles | N/A | N/A | -2,000 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -2,000 | 0 | 0 |
| Investing Cash Flow | $10,798 | $108 | $-2 | $6,253 | $-20,133 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -2,540 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | -1,960 | N/A | 10,000 | N/A |
| Common Stock Issued | 1 | 7,862 | 8 | 3,337 | 9 |
| Other Financing Activity | 0 | -611 | -528 | -1,048 | -1,047 |
| Financing Cash Flow | $-2,539 | $5,291 | $-520 | $12,289 | $-1,038 |
| Beginning Cash Position | 2,485 | 774 | 12,340 | 7,476 | 35,685 |
| End Cash Position | 5,181 | 2,485 | 774 | 12,340 | 7,476 |
| Net Cash Flow | $2,696 | $1,711 | $-11,566 | $4,864 | $-28,209 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,563 | -3,688 | -11,044 | -13,678 | -7,038 |
| Capital Expenditure | -75 | -214 | -135 | -23 | -147 |
| Free Cash Flow | -5,638 | -3,902 | -11,179 | -13,701 | -7,185 |